PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE
- PMID: 37490778
- DOI: 10.1097/IAE.0000000000003885
PREDICTORS OF 3-MONTH AND 1-YEAR VISUAL OUTCOMES AFTER VITRECTOMY WITH SUBRETINAL TISSUE PLASMINOGEN ACTIVATOR INJECTION FOR SUBMACULAR HEMORRHAGE
Abstract
Purpose: To investigate factors associated with 3-month or 1-year best-corrected visual acuity (BCVA) after vitrectomy with subretinal tissue plasminogen activator injection for submacular hemorrhage (SMH) and to identify the predictors of early displacement.
Methods: This prospective cohort study included consecutive eyes with SMH complicating neovascular age-related macular degeneration or retinal macroaneurysm that underwent vitrectomy with subretinal tissue plasminogen activator injection and were followed up for at least 3 months. Parameters that correlated with 3-month BCVA, 1-year BCVA, and 2-week displacement grade (0-3) were identified.
Results: Twenty-nine eyes of 29 patients (73.1 ± 8.4 years; neovascular age-related macular degeneration, 25 eyes) were included. Logarithm of the minimum angle of resolution BCVA improved 3 months after the surgery (baseline, 0.76 [20/115] ± 0.35; 3-month, 0.51 [20/65] ± 0.32; P = 0.006). In multivariable analyses, 1-year logarithm of the minimum angle of resolution BCVA correlated with age ( P = 0.007, β = 0.39) and SMH recurrence within 1 year after surgery ( P < 0.001, β = 0.65). Two-week displacement grade correlated with the contrast-to-noise ratio of SMH ( P = 0.001, β = -0.54). Macular hole occurred in three eyes (10%) with small SMH size and was closed in all eyes via additional vitrectomy with an inverted internal limiting membrane flap technique.
Conclusion: The recurrence of SMH negatively affected the 1-year visual outcome after vitrectomy with subretinal tissue plasminogen activator injection for SMH. The contrast-to-noise ratio was a useful predictor of early SMH displacement, but not of 1-year BCVA. Further research is necessary to determine the optimal treatment to prevent SMH recurrence.
Similar articles
-
Management of submacular massive haemorrhage in age-related macular degeneration: comparison between subretinal transplant of human amniotic membrane and subretinal injection of tissue plasminogen activator.Acta Ophthalmol. 2022 Aug;100(5):e1143-e1152. doi: 10.1111/aos.15045. Epub 2021 Oct 5. Acta Ophthalmol. 2022. PMID: 34609787 Clinical Trial.
-
The role of pigment epithelial detachment in AMD with submacular hemorrhage treated with vitrectomy and subretinal co-application of rtPA and anti-VEGF.Graefes Arch Clin Exp Ophthalmol. 2017 Jun;255(6):1115-1123. doi: 10.1007/s00417-017-3620-2. Epub 2017 Mar 9. Graefes Arch Clin Exp Ophthalmol. 2017. PMID: 28280989
-
Early surgical displacement of submacular hemorrhage without tissue plasminogen activator use: one-year outcomes.Can J Ophthalmol. 2024 Oct;59(5):e582-e589. doi: 10.1016/j.jcjo.2023.10.005. Epub 2023 Nov 1. Can J Ophthalmol. 2024. PMID: 37925165
-
Comparison of subretinal versus intravitreal injection of recombinant tissue plasminogen activator with gas for submacular hemorrhage secondary to wet age-related macular degeneration: treatment outcomes and brief literature review.Int Ophthalmol. 2021 Dec;41(12):4037-4046. doi: 10.1007/s10792-021-01976-x. Epub 2021 Jul 30. Int Ophthalmol. 2021. PMID: 34331185 Review.
-
Submacular hemorrhage: My personal journey to the goal.Graefes Arch Clin Exp Ophthalmol. 2024 Oct 31. doi: 10.1007/s00417-024-06671-y. Online ahead of print. Graefes Arch Clin Exp Ophthalmol. 2024. PMID: 39480559 Review.
References
-
- Kimura T, Araki T, Yasukawa T, et al. Differences in clinical characteristics and treatment outcomes of submacular hemorrhage caused by age-related macular degeneration and retinal macroaneurysms: a multicenter survey from the Japan Clinical Retina Study (J-CREST) group. PLoS One 2022;17:e0274508.
-
- Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762–773.
-
- Scupola A, Coscas G, Soubrane G, Balestrazzi E. Natural history of macular subretinal hemorrhage in age-related macular degeneration. Ophthalmologica 1999;213:97–102.
-
- Ohji M, Saito Y, Hayashi A, et al. Pneumatic displacement of subretinal hemorrhage without tissue plasminogen activator. Arch Ophthalmol 1998;116:1326–1332.
-
- Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900–1907; discussion 1906-1907.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical